Alignment Healthcare (ALHC) grants CFO 103,002 restricted stock units

Rhea-AI Filing Summary

Head James M reported acquisition or exercise transactions in this Form 4 filing.

Alignment Healthcare, Inc. reported that its Chief Financial Officer, James M. Head, received a grant of 103,002 restricted stock units of common stock. Each unit represents one share and will vest in roughly equal one-third installments on each of the first three anniversaries of the grant date, contingent on his continued service. Following this award, his direct common stock holdings total 184,595 shares.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Head James M

(Last) (First) (Middle)

1100 W. TOWN & COUNTRY ROAD

SUITE 1600

(Street)

ORANGE CA 92868

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Alignment Healthcare, Inc. [ ALHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
03/13/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/13/2026		A		103,002(1)	A	$0	184,595	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents 103,002 restricted stock units, each restricted stock unit representing the right to receive one share of Common Stock of the Company, that will vest approximately one third on each of the first three anniversaries of the grant date, subject to the reporting person's continued service to the Company as of the applicable vesting date.

Remarks:

	/s/ Christopher Joyce, as Attorney-in-Fact, for James M. Head	03/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Alignment Healthcare (ALHC) report for its CFO?

Alignment Healthcare reported a grant of 103,002 restricted stock units to CFO James M. Head. These units represent the right to receive common shares as they vest over time, increasing his equity-based compensation alignment.

How many shares does the Alignment Healthcare CFO hold after this Form 4 filing?

After the reported grant, CFO James M. Head directly holds 184,595 shares of Alignment Healthcare common stock. This total includes the newly awarded restricted stock units, which convert into shares as they vest over the three-year schedule.

How do the 103,002 restricted stock units for Alignment Healthcare’s CFO vest?

The 103,002 restricted stock units vest approximately one third on each of the first three anniversaries of the grant date. Vesting depends on the CFO’s continued service with Alignment Healthcare as of each applicable vesting date, reinforcing retention incentives.

What does a restricted stock unit grant mean for Alignment Healthcare insiders?

A restricted stock unit grant gives insiders the right to receive company shares in the future as vesting conditions are met. For Alignment Healthcare’s CFO, 103,002 units convert into common shares over three years, linking compensation more closely to long-term company performance.

Was the Alignment Healthcare CFO’s Form 4 transaction a market purchase or sale?

The Form 4 shows a grant classified as an acquisition, not an open-market trade. The CFO received 103,002 restricted stock units at no cash price, reflecting equity compensation rather than a traditional stock purchase or sale in the market.